February 2024 in “Archives of Dermatological Research” In this study conducted at the University of Michigan Alopecia Clinic, survey respondents demonstrated high awareness (97.9%) of topical minoxidil for hair loss, with medical professionals being the most influential information source (34%). Concerns about usage included continuous application (46.8%) and skepticism about regrowth (29.8%).
December 2025 in “Journal of Pharmacy And Bioallied Sciences” In this study, trichoscopy was found to enhance the early assessment of minoxidil therapy in males with pattern hair loss, leading to improved satisfaction and treatment compliance by revealing positive changes visible within one month.
3 citations
,
May 2022 in “Journal of The American Academy of Dermatology” This source notes that while low-dose oral minoxidil is effective for treating androgenetic alopecia, it has been associated with electrocardiogram changes and palpitations even at low doses.
June 2026 in “Minia Journal of Medical Research” This study found that applying 5% topical minoxidil gel on treatment-resistant vitiligo patches may promote early repigmentation, showing significant improvement at one month compared to a placebo, though later differences were not statistically significant.
March 2026 in “Journal of medical & health sciences review.” In this study, both 5% minoxidil foam and 5% minoxidil liquid solution effectively improved hair diameter and density in male patients with androgenetic alopecia over 12 weeks, with the foam formulation showing a slight advantage in patient satisfaction and hair density gain.